EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lifestyle Intervention Therapy Modulates Global DNA Methylation and Adipogenic Gene Expression in Severely Obese Hypogonadal Men

Siresha Bathina iD, Virginia Fuenmayor Lopez, Mia Prado, Salina Biene Teo iD, Dennis T Villareal, Rui Chen, Clifford Qualls, Reina Armamento-Villareal iD

Metabolites · 16.03.2026 · 16 (3) · 198

DOI: 10.3390/metabo16030198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metabolites, online erschienen am 16.03.2026. Verfasst von Siresha Bathina und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology Diabetes and Metabolism, Baylor College of Medicine, Houston, TX 77030, USA. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIH, VA Merit Review.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Previous studies have suggested that lifestyle intervention (LSI) therapies involving diet and exercise can modulate DNA methylation; however, whether this occurs in severely obese hypogonadal men undergoing weight loss from diet and exercise remains unclear.

Methods

In this study, we investigated the effects of weight loss from diet and exercise on global DNA methylation as well as on the mRNA expression of specific demethylation enzymes, DNMT1, DNMT3A, and DNMT3B—in peripheral blood mononuclear cells (PBMCs) and DNA methylation markers in DNA of severely obese hypogonadal men. This is a secondary analysis of samples of severely obese (body mass index of ≥35 kg/m2) hypogonadal men undergoing weight loss from diet and exercise in addition to an aromatase inhibitor (anastrozole) or placebo for a total of 12 months.

Results

LSI therapy significantly reduced global DNA methylation and 5-methylcytosine (5-mC) levels, decreased DNMT1, DNMT3A, and DNMT3B (p < 0.05) mRNA levels and markedly decreased CEBPα, FTO, and PPARγ mRNA expression. The reduction in global methylation was independent of aromatase inhibitor use.

Conclusions

In summary, our findings suggest that LSI induces epigenetic modifications in leukocytes, possibly through the regulation of DNMT gene expression. Future studies are warranted to clarify the mechanistic pathways linking lifestyle-induced epigenetic alterations to metabolic health outcomes.

Schlagwörter

Stichwörter der Autor:innen

DNA methylationhypogonadismlifestyle interventionobesity

Autor:innen und Institutionen

  • Division of Endocrinology Diabetes and Metabolism, Baylor College of Medicine, Houston, TX 77030, USA.
  • Department of Medicine, Michael E. DeBakey Veterans Affairs (VA) Medical Center, Houston, TX 77030, USA.
  • Office of Research, New Mexico VA Health Care System, Albuquerque, NM 87108, USA.

ORCID-Profile: Siresha Bathina, Salina Biene Teo, Reina Armamento-Villareal

Förderung

  • NIH HHS
  • NIH
  • VA Merit Review

Zitieren

APA

Bathina, S., Fuenmayor Lopez, V., Prado, M., Teo, S. B., Villareal, D. T., Chen, R., Qualls, C., & Armamento-Villareal, R. (2026). Lifestyle Intervention Therapy Modulates Global DNA Methylation and Adipogenic Gene Expression in Severely Obese Hypogonadal Men. Metabolites, 16(3), 198. https://doi.org/10.3390/metabo16030198

Vancouver

Bathina S, Fuenmayor Lopez V, Prado M, Teo SB, Villareal DT, Chen R, et al. Lifestyle Intervention Therapy Modulates Global DNA Methylation and Adipogenic Gene Expression in Severely Obese Hypogonadal Men. Metabolites. 2026;16(3):198. doi:10.3390/metabo16030198

BibTeX
@article{Bathina2026,
  author = {Bathina, Siresha and Fuenmayor Lopez, Virginia and Prado, Mia and Teo, Salina Biene and Villareal, Dennis T and Chen, Rui and Qualls, Clifford and Armamento-Villareal, Reina},
  title = {Lifestyle Intervention Therapy Modulates Global DNA Methylation and Adipogenic Gene Expression in Severely Obese Hypogonadal Men},
  journal = {Metabolites},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {198},
  doi = {10.3390/metabo16030198}
}
Kostenlos starten →